ASSENAGON ASSET MANAGEMENT S.A. BioCryst Pharmaceuticals, Inc. Transaction History

ASSENAGON ASSET MANAGEMENT S.A. portfolio value:

$32.96M
portfolio value

ASSENAGON ASSET MANAGEMENT S.A. quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -17.68% -561.71K shares -658K $12.6 2.61M
Q2 2022 share Increase +4385.73% 3.10M shares 32.47M $10.58 3.17M
Q1 2022 share Increase +435.24% 57.60K shares 969K $16.26 70.84K
Q4 2021 share Decrease -80.28% -53.89K shares -782K $13.79 13.23K
Q3 2021 share Decrease -91.11% -687.90K shares -10.97M $14.37 67.12K
Q2 2021 share Increase +1597.88% 710.56K shares 11.48M $15.81 755.03K
Q1 2021 share Increase 0.00% 44.46K shares 452K $10.17 44.46K
Q3 2020 share Decrease -100.00% -303.4K shares -1.44M $3.44 0
Q2 2020 share Increase 0.00% 303.4K shares 1.44M $4.76 303.4K
Q1 2020 share Decrease -100.00% -74.74K shares -258K $2 0
Q4 2019 share Increase 0.00% 74.74K shares 258K $3.45 74.74K